1442
BaiandCederbaum
preventingcelldeathbyactivationofantiapoptoticsignalingpathwaysneedtobeconsidered(MattsonandFurukawa,1997;Yuetal.,2003).
Serumdeprivationinducesoxidativestressincellsasdem-onstratedbyanexcessproductionofROS,suchassuperoxideanion,hydrogenperoxide,hydroxylradical,andorganicper-oxidesthatcanbeinhibitedbyintracellularantioxidants(Satohetal.,1996;Kingetal.,2003).WealsofoundthattroloxprotectsHepG2cellsfromserumwithdrawal-inducedcelldeath(Fig.2B).CHXmightincreaseresistancetooxida-tiveinsultsassuggestedbytheworkofRatanetal.(1994),whoshowedthatCHXcanenhancecellularantioxidantpathwaysbyshuntingcysteinefromglobalproteinsynthesisintotheformationoftheantioxidantglutathione.However,wedidnotdetectanyevidencethattheadministrationofCHXdecreasesintracellularROS(Fig.2A).Conversely,wefoundthattheROSlevelssignificantlyincreasedincellstreatedwithCHXcomparedwithcellsnottreatedwithCHXatthetimepointsof8and24hafterserumwithdrawal,whichmightbeexplainedbyCHXdecreasingthesynthesisofantioxidantenzymes,e.g.,catalaseandglutathionesyn-thase.Sa anchezetal.(1997)alsoreportedthatCHXpre-ventsapoptosis,ROSproduction,andreducedglutathionedepletioninducedbyTGF- infetalrathepatocytes.How-ever,theyconcludedthattheCHXprotectionagainstoxida-tivestressinducedbyTGF- infetalhepatocytesisnotrelatedtoanenhancementintheproductionofcellularan-tioxidants,suchasglutathione,asitappeared,therelation-shipbetweenTGF- inducedapoptosisandendogenouspro-ductionofROSwasnotcausalbutrathertheconsequenceofcelllysis.OurresultsindicatethattheprotectionbyCHXisnotduetoadecreaseinROSproductionafterserumwith-drawal.
p53isimplicatedincellcyclecontrol,DNArepair,andapoptosis(Liebermannetal.,1995;Steller,1995;Levine,1997).IthasbeenreportedthatCHXpreventedapoptosisofHeLacellsinducedbyp53(Yonish-Rouachetal.,1995).Inthecurrentstudy,wefoundthatserumwithdrawalinducesphosphorylationandaccumulationofp53.CHXdecreasestotalp53,pp53,p21,andBaxlevelsandblockscelldeath(Fig.3A).CHXalsoblockstheG1-Scellcyclearrestinducedbyserumwithdrawal,mostprobablyduetothedecreaseinp53andp21(Fig.3B).Thep53inhibitorpifithrin- protectsHepG2cellsfromserumwithdrawal-inducedcelldeath.Hep3Bcellslackingp53andHepG2cellsexpressingdomi-nantnegativep53aremoreresistanttoapoptosisinducedbyserumwithdrawalthancontrolcells(Fig.4).Decreasingp53levelsbytreatmentwithsiRNAofp53protectsHepG2cellsfromserumwithdrawal-inducedapoptosis(Fig.5).Thesedataindicatethatp53playsanimportantroleintheapopto-siscausedbyserumwithdrawalinHepG2cellsandthatanimportantmechanismbywhichCHXpreventscelldeathislinkedtotheCHX-mediateddeclineinp53andpp53levels.p53accumulationcausedbyDNAdamagingreagentsismainlyduetoposttranslationalmodificationssuchasp53phosphorylationcausedbyDNAkinases.Phosphorylatedp53hasalonghalf-lifecomparedwithnonphosphorylatedp53duetoitsslowerdegradation,whichthencausesp53accumulation.Thephosphorylatedp53canalsobedephos-phorylatedbyphosphatases.CHXinhibitionofp53proteinsynthesiscouldbeamajorexplanationforitsdecreasingtotalp53.However,itmightalsoregulatep53andpp53
levelsbyaffectingthephosphorylationordephosphorylationofp53viaactingonDNAkinasesorphosphatases.TostudytheeffectsofCHXonp53,ActDandthecancertherapeuticreagentsdoxorubicinandetoposidewereusedtoinducep53.Thesereagentsactivatep53andcauseincreasesofbothp53andpp53.CHXeffectivelydecreasesp53andpp53levelsinducedbythesereagents(Fig.6).TodeterminetheeffectsofCHXonphosphorylationordephosphorylationofp53,theproteasomeinhibitorMG115wasusedtomaintainthetotalp53levelataconstantlevel.MG115increasesthetotalp53level,butitdoesnotincreasethepp53level.InthepresenceofMG115,ActDdoesnotcauseanyfurtherincreaseintotalp53levelsoverthelevelsfoundwithMG115alone,butitdidincreasethepp53level.FourhoursaftertreatmentwithActDtoinducepp53,administrationofCHXfor6hdoesnotaffectthepp53levelcomparedwiththenoCHX-treatedlevels(Fig.7A).ThissuggeststhatCHXdoesnotstimulatethedephosphorylationofpp53.However,inthepresenceofMG115tomaintainthetotalp53levels,CHX,whenaddedtogetherwithActD,preventstheActDmediatedincreaseinpp53levels(Fig.7B).ThissuggeststhatCHXinhibitsthephosphorylationofp53andraisesthepossibilitythatkinasesthatphosphorylatep53mightbeinhibitedbyCHXadminis-tration.ATM,aDNAkinasethatcatalyzesp53phosphory-lation,wasthereforeevaluated.However,therewasnodif-ferenceincontentoractivityofATMinthepresenceandabsenceofCHX(datanotshown).Otherkinasesthatphos-phorylatep53willrequirefutureinvestigation.ThesedatademonstratethattheCHXdecreaseofp53andpp53levelsmightbemediatedthroughinhibitingp53proteinsynthesisandinhibitingthephosphorylationofp53.Thelatterwillalsodecreasethetotalp53levelsviaproteasomecatalyzeddegradationduetothelongerhalf-lifeofpp53thanp53.Insummary,theseexperimentsindicatethatCHXpro-tectsHepG2cellsfromserumwithdrawal-inducedapoptosis.Killerproteinp53isinvolvedintheapoptosisinducedbyserumwithdrawal.CHXdecreasesthep53andpp53levelviainhibitingp53proteinsynthesisanditsphosphorylation,therebypreventingcelldeath.
Acknowledgments
WethankJamesManfredi(MountSinaiRuttenbergCancerCen-ter)formanyhelpfulsuggestionsandadvice.
References
BaiJ,RodriguezAM,MelendezJA,andCederbaumAI(1999)OverexpressionofcatalaseincytosolicormitochondrialcompartmentprotectsHepG2cellsagainstoxidativeinjury.JBiolChem274:26217–26224.
DreyerEB,ZhangD,andLiptonSA(1995)Transcriptionalortranslationalinhibi-tionblockslowdoseNMDA-mediatedcelldeath.Neuroreport6:942–944.
el-DeiryWS,TokinoT,WaldmanT,OlinerJD,VelculescuVE,BurrellM,HillDE,HealyE,ReesJL,HamiltonSR,etal.(1995)Topologicalcontrolofp21WAF1/CIP1expressioninnormalandneoplastictissues.CancerRes55:2910–2919.
FritscheM,HaesslerC,andBrandnerG(1993)Inductionofnuclearaccumulationofthetumor-suppressorproteinp53byDNA-damagingagents.Oncogene8:307–318.FuldaS,MeyerE,andDebatinKM(2000)MetabolicinhibitorssensitizeforCD95(APO-1/Fas)-inducedapoptosisbydown-regulatingFas-associateddeathdomain-likeinterleukin1-convertingenzymeinhibitoryproteinexpression.CancerRes60:3947–3956.
HermekingH,LengauerC,PolyakK,HeTC,ZhangL,ThiagalingamS,KinzlerKW,andVogelsteinB(1997)14-3-3sigmaisap53-regulatedinhibitorofGCell1:3–11.
2/Mprogres-sion.MolKangS,SongJ,KangH,KimS,LeeY,andParkD(2003)Insulincanblockapoptosisbydecreasingoxidativestressviaphosphatidylinositol3-kinase-andextracellularsignal-regulatedproteinkinase-dependentsignalingpathwaysinHepG2cells.EurJEndocrinol148:147–155.
KastanMB,ZhanQ,el-DeiryWS,CarrierF,JacksT,WalshWV,PlunkettBS,VogelsteinB,andFornaceAJJr(1992)Amammaliancellcyclecheckpointpathwayutilizingp53andGADD45isdefectiveinataxia-telangiectasia.Cell71:587–597.
cycloheximide, or TNF-a (Wang et al., 1999; ...and hepatocellular carcinoma HepG2 cells transduced ...Activated YSK1 phosphorylated 14-3-3 and ...
and phosphorylated p70S6K by PQIP in 3T3/ huIGF1R...IR was 261 nmol/L in HepG2 cells (Table 2)...In addition, activation of the IGF-IR protects ...
and phosphorylated p70S6K by PQIP in 3T3/ huIGF1R...IR was 261 nmol/L in HepG2 cells (Table 2)...In addition, activation of the IGF-IR protects ...
热门文档